0001493152-26-003327.txt : 20260123 0001493152-26-003327.hdr.sgml : 20260123 20260123092746 ACCESSION NUMBER: 0001493152-26-003327 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260123 DATE AS OF CHANGE: 20260123 EFFECTIVENESS DATE: 20260123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genesis BioCapital Fund I, LP CENTRAL INDEX KEY: 0002053141 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-536080 FILM NUMBER: 26553648 BUSINESS ADDRESS: STREET 1: 200 WEST MLK BLVD. STREET 2: SUITE 1000, PMB #3073 CITY: CHATTANOOGA STATE: TN ZIP: 37402 BUSINESS PHONE: 617-444-8400 MAIL ADDRESS: STREET 1: 200 WEST MLK BLVD. STREET 2: SUITE 1000, PMB #3073 CITY: CHATTANOOGA STATE: TN ZIP: 37402 D/A 1 primary_doc.xml X0708 D/A LIVE 0002053141 Genesis BioCapital Fund I, LP 200 WEST MLK BLVD. SUITE 1000, PMB #3073 CHATTANOOGA TN TENNESSEE 37402 617-444-8400 DELAWARE None None Limited Partnership true 2024 - Genesis BioCapital Fund I GP, LP 200 West MLK Blvd. Suite 1000, PMB #3073 Chattanooga TN TENNESSEE 37402 Executive Officer General Partner - Genesis BioCapital Management, LLC 200 West MLK Blvd. Suite 1000, PMB #3073 Chattanooga TN TENNESSEE 37402 Executive Officer Investment Manager Ray Tabibiazar 200 West MLK Blvd. Suite 1000, PMB #3073 Chattanooga TN TENNESSEE 37402 Executive Officer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 true 0001493152-25-003393 2025-01-24 true true false 0 Indefinite 18480000 Indefinite false 21 0 0 0 true The Investment Manager will receive a fee based on each limited partner's capital commitments and the General Partner may receive incentive distributions as more fully set forth in the offering materials. false Genesis BioCapital Fund I, LP /s/ Ray Tabibiazar Ray Tabibiazar Authorized Signatory 2026-01-23